Introduction
The molecular biology of these monogenetic skin diseases has been approached in two ways. The first was initiated by ultrastructural observations postulating mutations in the structural proteins of the cell so that linkage and keratin mutations could be extrapolated. The second approach has been by the use of transgenic mice technology to produce the phenotypes of human blistering skin diseases with specific keratin gene mutations.
Over the last 10 years dermatology has been in the forefront of academic research examining the genetic basis of monogenetic diseases and has used the powerfully combined approaches of molecular biology, morphological studies, immunohistochemist.y and biochemical studies. The key to these developments has been the polymerase chain reaction (PCR) which has made linkage analysis and gene sequencing possible. The target genes for the hereditary genodermatoses were identified using biochemical, immunohistochemical and positional cloning techniques which has given molecular genetics the power to unravel the nature ofthe keratin gene mutations. Keratin mutations in a number of genodermatoses (epidermolytic hyperkeratosis; epidermolysis bullosa simplex, Weber-Cockayne, Koebner and epidermolytic palmoplantar keratoderma) have now been determined and all have two common features. The first, epidermolysis or blistering, is a prominent histological feature. Secondly, the mutations all lie in four highly conserved subdomains common to all the keratins. These subdomains are important in filament assembly. Mutations at these critical points result in perturbation of keratin assembly, and result in epidermolysis, seen in both the affected individuals as well as in transgenic mice.
The keratin cytoskeleton
The keratins comprise a heterogeneous group of more than 30 distinct proteins. The cellular keratins have a major protective and structural role which comprises 90% of the total protein of the differentiated keratinocytes. All keratins have the same basic structure ( Figure 1 ) and are numbered on the basis of their migration by two-dimensional gel electrophoresis.' The common structural components of the keratin polypeptide ( Figure 1 ) are a central a-helical rod which is comprised of four segments (lA, 1B, 2A, 2B), lying between each of these four segments is a non-helical linkage segment (LI, L12, L2), and in the type two keratins the a-helical rod is flanked at each end by a homology
The keratins (K) provide the intermediate filament network that forms the cytoskeleton of epithelial cells. Specific pairs of type I (K9-K 19; small acidic proteins) and type II (KI -K8; larger basic or neutral proteins) keratins are coexpressed during various stages of epithelial differentiation. In the absence of the corresponding keratin partner, single keratins are degraded within the cell. The keratins expressed are fundamental to the cellular differentiation and phenotype of the epithelial cell.4 These coexpressed keratin polypeptides form dimers with a coiled-coil structure in a 1: 1 ratio. The dimers polymerize to form tetramers. These tetramers in turn polymerize to form intermediate filaments (10 nm in diameter) of the cytoskeleton. The process of heterodimer formation is believed to result from molecular interactions in the highly conserved regions at the beginning and the end of the keratin a-helical rod domains.
In an analogous fashion to the switching from fetal to adult haemoglobin after birth, the keratin expression is influenced by the maturation and terminal differentiation of the keratinocytes in the epidermis from which the cells are derived. K8 and K18 are the primary epithelial keratins expressed in the fetus and in all simple epithelia. K5 and K14 are first detectable in embryonic based cells and are the primary keratins expressed by all keratinocytes in stratified non-secreting epithelia in which cells high levels of expression are seen.
In stratified epithelia the keratin expression profile changes with the passage of the keratinocyte from the basal to suprabasal layers of the epithelium.7'8 In the basal layer, whilst the keratinocyte is in contact with the basement membrane, K5 and K14 are expressed. In the suprabasal layers of the skin, K1 and KIO are expressed, and in the stratified squamous oral and genital mucosa K6 and K16 are expressed.' K6 and K16 are also expressed by hyperproliferative and hyperkeratotic epithelia such as on the palm and sole and during wound healing.'
Disordered intermediate filament cytoskeleton
The first suggestion of keratin mutations being involved in the pathogenesis of the autosomal dominant skin diseases came from ultrastructural studies. This was facilitated by the realization ofthe genetic concept that recessive disorders were most commonly the result of enzyme deficiencies, whilst dominant disorders usually resulted from defects in regulatory or structural proteins.9"'0 The reasoning behind this concept is that a reduction in enzyme concentration of 50% will not significantly affect metabolic function, but an alteration in the physical properties of 50% of a specific structural protein could result in major morphological disturbance as in sickle cell disease.
Epidermolytic hyperkeratosis
Epidermolytic hyperkeratosis (EH) is a group of inherited skin diseases which include bullous congenital ichthyosiform erythroderma (BCIE), ichthyosis hystrix of Curth-Macklin (IHCM) and ichthyosis bullosa of Siemens (IBS). In EH the basal cells are normal, and there is suprabasal tonofilament clumping which appears to be the primary event with secondary cytolysis of the suprabasal cells, blister formation and hyperkeratosis.9 BCIE presents soon after birth with erythroderma and severe blistering, the denuded areas healing rapidly with recurrent episodes ofblistering on the background of erythroderma. With time, a verrucous hyperkeratosis becomes progessively more prominent with a linear distribution in the flexures. " Immunohistochemical staining with specific monoclonal antibodies to keratin polypeptides demonstrated tonofilament abnormalities only in the stratified epithelia in which keratins KI and KIO are expressed, but not in cultured keratinocytes or non-stratified epithelia. Immunoelectron microscopy demonstrated that, among the keratins detected in the suprabasal epidermis, the clumped tonofilaments predominantly expressed KI Weber-Cockayne EBS is the commonest and least severe form of EBS and presents with blistering confined to sites of greatest trauma, such as the hands and feet. Children tend not to be affected until they start to walk and the blistering tends to be worse in warm weather. In Weber-Cockayne EBS linkage studies have mapped affected families to the keratin gene cluster on chromosome 12 and, as the disease is restricted to the palmoplantar epidermis, have suggested that site-specific keratins such as K9 or K16 may be involved. [22] [23] [24] The blistering in patients with Koebner EBS occurs within the first few weeks of life but again develops at sites of trauma. In Koebner EBS the tonofilament clumping and condensation observed in these patients was so minor that it was considered to be the consequence ofthe cytolysis rather than the cause of it.
Dowling-Meara EBS is the most uncommon and most severe form of EBS, and presents at birth or in early infancy with grouped and generalized skin blistering at sites of mild skin trauma. In addition there is an associated palmoplantar hyperkeratosis, nail dystrophy and oral ulceration. 25 The locations of keratin gene mutations in the keratin polypeptide are clustered at a number of mutational 'hot spots' along the keratin polypeptide. The sites for the point mutations seen in EH, EBS and EPPK are surprisingly restricted to particular domains of the keratin chain and also particular points within that chain are susceptible to mutation. These mutation 'hot spots' lie in the H 1, 1A, L12 and 2B domains of the keratin chain. For the mutations so far identified, no domain is specific for any particular disease type, and a similar mutation in a different keratin appears to produce a different clinical disease.
With our greater understanding of intermediate filament structure and function, the differences between naturally occurring keratin polymorphisms and pathological keratins is being unravelled. The mutational 'hot spots' give important information on the highly conserved regions in intermediate filament structure and assembly.
Our understanding of keratin polypeptide structure and function is still in its infancy. We do not know the nature of the molecular interactions that are responsible for the maintenance of the integrity of the cellular cytoskeleton nor how the keratin 
